CompuGroup Medical SE & Co. KGaA
CMPUY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -1.40 | -1.13 | 3.92 | -17.24 |
| FCF Yield | 5.69% | 5.73% | 3.26% | 2.51% |
| EV / EBITDA | 9.31 | 12.47 | 11.65 | 19.31 |
| Quality | ||||
| ROIC | 3.52% | 4.99% | 5.37% | 5.08% |
| Gross Margin | 83.64% | 84.62% | 84.81% | 84.97% |
| Cash Conversion Ratio | 3.71 | 3.83 | 1.96 | 2.39 |
| Growth | ||||
| Revenue 3-Year CAGR | 0.71% | 5.02% | 10.50% | 11.19% |
| Free Cash Flow Growth | -41.21% | 74.52% | -27.10% | -6.82% |
| Safety | ||||
| Net Debt / EBITDA | 3.74 | 3.30 | 3.05 | 2.96 |
| Interest Coverage | 2.69 | 5.02 | 9.86 | 20.13 |
| Efficiency | ||||
| Inventory Turnover | 12.84 | 9.67 | 5.83 | 7.47 |
| Cash Conversion Cycle | -88.20 | -83.59 | -105.26 | -106.82 |